News Daily News SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients L.A. McKeown October 23, 2024
News Daily News Defying Earlier GLP-1 Data, Study in Teens Sees Possible Mental Health Gains L.A. McKeown October 22, 2024
News Features Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts Michael O'Riordan October 21, 2024
News Daily News Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction Todd Neale October 15, 2024
News Daily News Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge L.A. McKeown October 15, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Conference News EACTS 2024 Will Semaglutide Change Cardiac Surgery? It Already Has Yael L. Maxwell October 10, 2024
News Daily News Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits Michael O'Riordan October 03, 2024
News Daily News High Levels of Metals, Particularly Cadmium, Linked to Subclinical CVD Michael O'Riordan September 23, 2024
News Daily News Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE Yael L. Maxwell September 23, 2024
News Conference News ESC 2024 New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower Yael L. Maxwell September 04, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Daily News ACC/AHA Clarify How Social Determinants of Health Impact CVD Caitlin E. Cox August 28, 2024
News Daily News ‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database Michael O'Riordan August 21, 2024
News Daily News CMS Announces Negotiated Medicare Prices for First 10 Drugs Yael L. Maxwell August 16, 2024
News Daily News PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives Michael O'Riordan August 02, 2024